Vascular smooth muscle growth: Autocrine growth mechanisms

被引:306
作者
Berk, BC [1 ]
机构
[1] Univ Rochester, Sch Med & Dent, Cardiovasc Res Ctr, Rochester, NY 14642 USA
关键词
D O I
10.1152/physrev.2001.81.3.999
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Vascular smooth muscle cells (VSMC) exhibit several growth responses to agonists that regulate their function including proliferation (hyperplasia with an increase in cell number), hypertrophy (an increase in cell size without change in DNA content), endoreduplication (an increase in DNA content and usually size), and apoptosis. Both autocrine growth mechanisms (in which the individual cell synthesizes and/or secretes a substance that stimulates that same cell type to undergo a growth response) and paracrine growth mechanisms (in which the individual cells responding to the growth factor synthesize and/or secrete a substance that stimulates neighboring cells of another cell type) are important in VSMC growth. In this review I discuss the autocrine and paracrine growth factors important for VSMC growth in culture and in vessels. Four mechanisms by which individual agonists signal are described: direct effects of agonists on their receptors, transactivation of tyrosine kinase-coupled receptors, generation of reactive oxygen species, and induction/secretion of other growth and survival factors. Additional growth effects mediated by changes in cell matrix are discussed. The temporal and spatial coordination of these events are shown to modulate the environment in which other growth factors initiate cell cycle events. Finally, the heterogeneous nature of VSMC developmental origin provides another level of complexity in VSMC growth mechanisms.
引用
收藏
页码:999 / 1030
页数:32
相关论文
共 350 条
  • [101] CLONAL GROWTH OF BOVINE VASCULAR ENDOTHELIAL CELLS - FIBROBLAST GROWTH-FACTOR AS A SURVIVAL AGENT
    GOSPODAROWICZ, D
    MORAN, J
    BRAUN, D
    BIRDWELL, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (11) : 4120 - 4124
  • [102] Expression of IGF-1, IGF-1 receptor and TGF-β following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries:: An immunocytochemical study
    Grant, MB
    Wargovich, TJ
    Bush, DM
    Player, DW
    Caballero, S
    Foegh, M
    Spoerri, PE
    [J]. REGULATORY PEPTIDES, 1999, 79 (01) : 47 - 53
  • [103] ANGIOTENSIN-II STIMULATES NADH AND NADPH OXIDASE ACTIVITY IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS
    GRIENDLING, KK
    MINIERI, CA
    OLLERENSHAW, JD
    ALEXANDER, RW
    [J]. CIRCULATION RESEARCH, 1994, 74 (06) : 1141 - 1148
  • [104] Redox control of vascular smooth muscle proliferation
    Griendling, KK
    Ushio-Fukai, M
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (01): : 9 - 15
  • [105] Griendling KK, 1997, CIRCULATION, V96, P3264
  • [106] Angiotensin II signaling in vascular smooth muscle - New concepts
    Griendling, KK
    UshioFukai, M
    Lassegue, B
    Alexander, RW
    [J]. HYPERTENSION, 1997, 29 (01) : 366 - 373
  • [107] ANGIOTENSIN-II CAUSES VASCULAR HYPERTROPHY IN PART BY A NON-PRESSOR MECHANISM
    GRIFFIN, SA
    BROWN, WCB
    MACPHERSON, F
    MCGRATH, JC
    WILSON, VG
    KORSGAARD, N
    MULVANY, MJ
    LEVER, AF
    [J]. HYPERTENSION, 1991, 17 (05) : 626 - 635
  • [108] GRONWALD RGK, 1989, J BIOL CHEM, V264, P8120
  • [109] Guay J, 1997, J CELL SCI, V110, P357
  • [110] The third cytoplasmic loop of the angiotensin II type 1 receptor exerts differential effects on extracellular signal-regulated kinase (ERK1/ERK2) and apoptosis via Ras- and Rap1-dependent pathways
    Haendeler, J
    Ishida, M
    Hunyady, L
    Berk, BC
    [J]. CIRCULATION RESEARCH, 2000, 86 (07) : 729 - 736